John Ioannidis
Publications
- Are mortality differences detected by administrative data reliable and actionable? JAMA. 2013; (13): 1410-1
- Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. BMJ. 2013: f707
- Mega-trials for blockbusters. JAMA. 2013; (3): 239-40
- Patient safety strategies targeted at diagnostic errors: a systematic review. Ann Intern Med. 2013; (5 Pt 2): 381-9
- A nutrient-wide association study on blood pressure. Circulation. 2012; (21): 2456-64
- Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012; (16): 1676-84
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012; (5): 491-501
- Reversals of established medical practices: evidence to abandon ship. JAMA. 2012; (1): 37-8
- The importance of potential studies that have not existed and registration of observational data sets. JAMA. 2012; (6): 575-6
- Improving validation practices in "omics" research. Science. 2011; (6060): 1230-2
- Individualized cost-effectiveness analysis. PLoS Med. 2011; (7): e1001058
- More time for research: fund people not projects. Nature. 2011; (7366): 529-31
- Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013; (7431): 216-20
- Are randomized trials obsolete or more important than ever in the genomic era? Genome Med. 2013; (4): 32
- Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet. 2013; (2): 167-78
- Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med. 2013; (8): 664-71
- Biomarker failures. Clin Chem. 2013; (1): 202-4
- Demystifying trial networks and network meta-analysis. BMJ. 2013: f2914
- Distinguishing true from false positives in genomic studies: p values. Eur J Epidemiol. 2013; (2): 131-8
- Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials. Heart Rhythm. 2013; (2): 200-6
- Emergence of large treatment effects from small trials--reply. JAMA. 2013; (8): 768-9
- Expressing Death Risk as Condensed Life Experience and Death Intensity. Med Decis Making. 2013
- Informed consent, big data, and the oxymoron of research that is not research. Am J Bioeth. 2013; (4): 40-2
- Is everything we eat associated with cancer? A systematic cookbook review. Am J Clin Nutr. 2013; (1): 127-34
- Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev. 2013; (1): 3-10
- Limitations of medical research and evidence at the patient-clinician encounter scale. Chest. 2013; (4): 1127-35
- Mega-randomized clinical trials for blockbuster drugs--reply. JAMA. 2013; (16): 1683
- Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet. 2013
- Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. J Clin Epidemiol. 2013; (4): 371-8
- NIH funding: The critics respond. Nature. 2013; (7430): 26
- Narrow band imaging to differentiate neoplastic and non-neoplastic colorectal polyps in real time: a meta-analysis of diagnostic operating characteristics. Gut. 2013
- Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes. J Clin Epidemiol. 2013; (4): 361-366.e4
- Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev. 2013; (2): 189-200
- Optimal type I and type II error pairs when the available sample size is fixed. J Clin Epidemiol. 2013
- Pancreatitis Potentially Associated Drugs as a Risk Factor for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Cohort Study. Pancreas. 2013; (4): 601-606
- Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci. 2013; (5): 365-76
- Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study. PLoS One. 2013; (2): e55712
- Seven new loci associated with age-related macular degeneration. Nat Genet. 2013; (4): 433-9, 439e1-2
- Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum Genet. 2013; (5): 495-508
- Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. Clin Biochem. 2013; (6): 432-43
- The DOT1L rs12982744 polymorphism is associated with osteoarthritis of the hip with genome-wide statistical significance in males. Ann Rheum Dis. 2013
- This I believe in genetics: discovery can be a nuisance, replication is science, implementation matters. Front Genet. 2013: 33
- Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013; (4): 508-16
- Trends in citations to books on epidemiological and statistical methods in the biomedical literature. PLoS One. 2013; (5): e61837
- Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Eur J Clin Invest. 2013; (5): 469-75
- A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet. 2012; (11): 721-6
- Are medical conferences useful? And for whom? JAMA. 2012; (12): 1257-8
- Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res. 2012; (10): 2051-64
- Authors' reply to Noble and colleagues and Liew and colleagues. BMJ. 2012: e4360
- Calculating additive treatment effects from multiple randomized trials provides useful estimates of combination therapies. J Clin Epidemiol. 2012; (12): 1282-8
- Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review. Eur J Clin Invest. 2012; (3): 233-44
- Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst. 2012; (7): 528-40
- Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012: e3318
- Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012; (3): e1002548
- Concordance of sleep and pain outcomes of diverse interventions: an umbrella review. PLoS One. 2012; (7): e40891
- Consistency of genome-wide associations across major ancestral groups. Hum Genet. 2012; (7): 1057-71
- Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses? BMJ. 2012: e7031
- Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology. 2012; (6): 902-9
- Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012; (7): 851-62
- Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses. Pediatrics. 2012: S161-84
- Erratum to: STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Epidemiol. 2012
- Estimating the contribution of genetic variants to difference in incidence of disease between population groups. Eur J Hum Genet. 2012; (8): 831-6
- Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. J Natl Cancer Inst. 2012; (24): 1867-78
- Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet. 2012; (8): 886-9
- Extrapolating from animals to humans. Sci Transl Med. 2012; (151): 151ps15
- Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Int J Epidemiol. 2012; (6): 1764-75
- Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology. 2012; (9): 1874-85
- How to use an article reporting a multiple treatment comparison meta-analysis. JAMA. 2012; (12): 1246-53
- Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet. 2012; (9844): 815-23
- Implementation of proteomic biomarkers: making it work. Eur J Clin Invest. 2012; (9): 1027-36
- Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technol Assess. 2012; (35): 1-82
- Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med. 2012; (6): 429-38
- Invited commentary-Genetic prediction for common diseases. Arch Intern Med. 2012; (9): 744-6
- Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012; (11): 1771-82
- Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology. 2012; (7): 659-67
- METRADISC-XL: a program for meta-analysis of multidimensional ranked discovery oriented datasets including microarrays. Comput Methods Programs Biomed. 2012; (3): 1243-6
- Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA. 2012; (15): 1636-40
- Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. Circ Res. 2012; (5): 658-62
- Neglected tropical diseases: survey and geometry of randomised evidence. BMJ. 2012: e6512
- Obtaining evidence by a single well-powered trial or several modestly powered trials. Stat Methods Med Res. 2012
- Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics. 2012; (2): 285-92
- Perceived information gain from randomized trials correlates with publication in high-impact factor journals. J Clin Epidemiol. 2012; (12): 1274-81
- Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. J Clin Epidemiol. 2012; (7): 740-7
- Randomized trial of personal genomics for preventive cardiology: design and challenges. Circ Cardiovasc Genet. 2012; (3): 368-76
- Re-rethinking the article by Thombs and colleagues. CMAJ. 2012; (4): 438-9
- Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol. 2012; (3): 686-704
- Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry. 2012: e156
- Reproducibility concerns. Nat Med. 2012; (12): 1736-7
- Research grants: Conform and be funded. Nature. 2012; (7427): 34-6
- Research needs grants, funding and money--missing something? Eur J Clin Invest. 2012; (4): 349-51
- Rethinking recommendations for screening for depression in primary care. CMAJ. 2012; (4): 413-8
- STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Clin Invest. 2012; (1): 1-16
- STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Mutagenesis. 2012; (1): 17-29
- STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement. J Epidemiol Community Health. 2012; (9): 844-54
- Scientific inbreeding and same-team replication: type D personality as an example. J Psychosom Res. 2012; (6): 408-10
- Sex-specific differences in effect size estimates at established complex trait loci. Int J Epidemiol. 2012; (5): 1376-82
- Standard 6: age groups for pediatric trials. Pediatrics. 2012: S153-60
- Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol. 2012; (3): 828-43
- TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet. 2012; (8): 916-21
- The effectiveness of long-term psychoanalytic psychotherapy--a meta-analysis of randomized controlled trials. Clin Psychol Rev. 2012; (2): 81-92
- There is nothing personal-reply. Arch Intern Med. 2012; (21): 1691-2
- To Correct or Not to Correct-and How. Epidemiology. 2012; (6): 912-3
- What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol. 2012; (1): 273-86
- A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging. 2011; (3): 548.e9-18
- A roadmap for successful applications of clinical proteomics. Proteomics Clin Appl. 2011; (5-6): 241-7
- Allergens responsible for allergic contact dermatitis among children: a systematic review and meta-analysis. Contact Dermatitis. 2011; (5): 245-57
- An empirical assessment of validation practices for molecular classifiers. Brief Bioinform. 2011; (3): 189-202
- An epidemic of false claims. Competition and conflicts of interest distort too many medical findings. Sci Am. 2011; (6): 16
- Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol. 2011; (10): 898-908
- Commentary: Adjusting for bias: a user's guide to performing plastic surgery on meta-analyses of observational studies. Int J Epidemiol. 2011; (3): 777-9
- Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011; (18): 3699-709
- Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA. 2011; (21): 2200-10
- Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst. 2011; (16): 1227-35
- Different black box warning labeling for same-class drugs. J Gen Intern Med. 2011; (6): 603-10
- EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011; (3): 414-22
- Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011; (8): 773-80
- First-trimester ductus venosus screening for cardiac defects: a meta-analysis. BJOG. 2011; (12): 1438-45
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011; (2): 163-71
- Guidelines on chemotherapy in advanced stage gynecological malignancies: an evaluation of 224 professional societies and organizations. PLoS One. 2011; (5): e20106
- Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. J Clin Epidemiol. 2011; (8): 830-42
- Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection. Am J Epidemiol. 2011; (11): 1336-42
- Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011; (5): 778-92
- Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test. CMAJ. 2011; (6): E337-43
- Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis. 2011; (5): 864-7
- Magnitude of effects in clinical trials published in high-impact general medical journals. Int J Epidemiol. 2011; (5): 1280-91
- Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis. 2011; (2): 349-55
- Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS One. 2011; (9): e24384
- New prognostic markers for outcome of acute pancreatitis: overview of reporting in 184 studies. Pancreas. 2011; (4): 522-32
- Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J. 2011; (1): 32-40
- Polymorphisms in the 5' flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteoporos Int. 2011; (3): 911-21
- Predicting death: an empirical evaluation of predictive tools for mortality. Arch Intern Med. 2011; (19): 1721-6
- Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study. BMJ. 2011: d6829
- Public availability of published research data in high-impact journals. PLoS One. 2011; (9): e24357
- Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination. PLoS One. 2011; (12): e28346
- Quantifying selective reporting and the Proteus phenomenon for multiple datasets with similar bias. PLoS One. 2011; (3): e18362
- Re: Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition. J Natl Cancer Inst. 2011; (3): 279-80; author reply 280-1
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011: d4002
- Replication of genome-wide discovered breast cancer risk loci in the Cypriot population. Breast Cancer Res Treat. 2011; (1): 267-72
- Risk factors and interventions with statistically significant tiny effects. Int J Epidemiol. 2011; (5): 1292-307
- Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiol Aging. 2011; (11): 2108.e1-5
- STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Prev Med. 2011; (6): 377-87
- STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med. 2011; (10): e1001117
- STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology STROBE-ME: an extension of the STROBE statement. J Clin Epidemiol. 2011; (12): 1350-63
- STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Epidemiol. 2011; (10): 797-810
- Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects. J Clin Epidemiol. 2011; (10): 1060-9
- Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol. 2011; (8): e1-e22
- Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. J Clin Epidemiol. 2011; (8): 843-7
- Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med. 2011; (3): e1000420
- Strengthening the reporting of Genetic Risk Prediction Studies: the GRIPS statement. Genet Med. 2011; (5): 453-6
- Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest. 2011; (9): 1010-35
- Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol. 2011; (4): 313-37
- Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet. 2011; (5): 18 p preceding 494
- Strengthening the reporting of genetic risk prediction studies: The GRIPS Statement. Ann Intern Med. 2011; (6): 421-5
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol. 2011; (4): 255-9
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Hum Genet. 2011; (8): 833-6
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Circ Cardiovasc Genet. 2011; (2): 206-9
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Genome Med. 2011; (3): 16
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ. 2011: d631
- Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Clin Invest. 2011; (9): 1004-9
- The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis. 2011; (5): 873-5
- The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011; (4): 450-6
- Understanding and harnessing the health effects of rapid urbanization in China. Environ Sci Technol. 2011; (12): 5099-104
- Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol. 2011; (4): 1094-105
- Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev. 2011; (6): 341-52
- X-WAS, Traditional Epidemiology, and Policy Action. Epidemiology. 2011; (4): 467-8
- A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J Natl Cancer Inst. 2010; (12): 846-58
- A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum. 2010; (2): 499-510
- A vision for the European journal of clinical investigation: note from the new editors. Eur J Clin Invest. 2010; (1): 1-3
- Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010: 85
- Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines. Pharmacogenet Genomics. 2010; (10): 586-97
- Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners. J Appl Physiol. 2010; (3): 567-74
- Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends Genet. 2010; (3): 132-41
- Comparative effectiveness of medical interventions in adults versus children. J Pediatr. 2010; (2): 322-330.e17
- Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia". Biol Psychiatry. 2010; (7): e45-8
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010; (12): 2074-82
- Evaluating novel agent effects in multiple-treatments meta-regression. Stat Med. 2010; (23): 2369-83
- Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One. 2010; (5): e10858
- Expectations, validity, and reality in omics. J Clin Epidemiol. 2010; (9): 945-9
- Fifty-year fate and impact of general medical journals. PLoS One. 2010; (9)
- Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010; (5): 441-7
- Genome-wide significant associations for variants with minor allele frequency of 5% or less--an overview: A HuGE review. Am J Epidemiol. 2010; (8): 869-89
- Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously. Hypertension. 2010; (6): 1301-3
- Industry sponsorship and selection of comparators in randomized clinical trials. Eur J Clin Invest. 2010; (2): 172-82
- Is there a glass ceiling for highly cited scientists at the top of research universities? FASEB J. 2010; (12): 4635-8
- Laboratory mouse models for the human genome-wide associations. PLoS One. 2010; (11): e13782
- Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet. 2010; (1): 220-8
- Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy. J Gen Intern Med. 2010; (9): 914-9
- Primary open angle glaucoma due to T377M MYOC: Population mapping of a Greek founder mutation in Northwestern Greece. Clin Ophthalmol. 2010: 171-8
- Published articles should not be dead and buried: introducing research updates. Eur J Clin Invest. 2010; (9): 767-9
- Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med. 2010; (46): 46ps42
- Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur J Hum Genet. 2010; (7): 832-7
- Science mapping analysis characterizes 235 biases in biomedical research. J Clin Epidemiol. 2010; (11): 1205-15
- Selection and presentation of imaging figures in the medical literature. PLoS One. 2010; (5): e10888
- Sources of funding for Nobel Prize-winning work: public or private? FASEB J. 2010; (5): 1335-9
- Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis. Ann Rheum Dis. 2010; (3): 561-6
- Synopsis of preterm birth genetic association studies: the preterm birth genetics knowledge base (PTBGene). Public Health Genomics. 2010; (7-8): 514-23
- The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol. 2010; (5): 517-24
- The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence. BMJ. 2010: c4875
- Validation of the Greek translation of the Dundee Ready Education Environment Measure (DREEM). Educ Health (Abingdon). 2010; (1): 348
- What makes a good predictor?: the evidence applied to coronary artery calcium score. JAMA. 2010; (16): 1646-7
- Who is afraid of reviewers' comments? Or, why anything can be published and anything can be cited. Eur J Clin Invest. 2010; (4): 285-7
- A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst. 2009; (1): 24-36
- Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med. 2009; (19): 1737-9
- An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses. Genet Med. 2009; (3): 153-62
- Assessment of claims of improved prediction beyond the Framingham risk score. JAMA. 2009; (21): 2345-52
- Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2009; (1): 276-86
- Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med. 2009; (8): 528-37
- Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev. 2009; (7): 570-3
- Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev. 2009; (4): CD006614
- Discovery properties of genome-wide association signals from cumulatively combined data sets. Am J Epidemiol. 2009; (10): 1197-206
- Double versus single stenting for coronary bifurcation lesions: a meta-analysis. Circ Cardiovasc Interv. 2009; (5): 409-15
- EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Ann Rheum Dis. 2009; (4): 470-6
- EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. Ann Rheum Dis. 2009; (4): 477-83
- Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009; (3): 269-79
- Heterogeneous views on heterogeneity. Int J Epidemiol. 2009; (6): 1740-2
- How to use an article about genetic association: A: Background concepts. JAMA. 2009; (1): 74-81
- How to use an article about genetic association: B: Are the results of the study valid? JAMA. 2009; (2): 191-7
- How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? JAMA. 2009; (3): 304-8
- Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect Dis. 2009; (8): 482-92
- Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009; (8): 488-93
- Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 2009; (6): 1710-21
- Meta-analysis in genome-wide association studies. Pharmacogenomics. 2009; (2): 191-201
- Overinterpretation of clinical applicability in molecular diagnostic research. Clin Chem. 2009; (4): 786-94
- Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis. Am Heart J. 2009; (4): 695-701
- Personalized genetic prediction: too limited, too expensive, or too soon? Ann Intern Med. 2009; (2): 139-41
- Population-wide generalizability of genome-wide discovered associations. J Natl Cancer Inst. 2009; (19): 1297-9
- Prediction of cardiovascular disease outcomes and established cardiovascular risk factors by genome-wide association markers. Circ Cardiovasc Genet. 2009; (1): 7-15
- Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer. 2009; (13): 2367-75
- Ranking antidepressants. Lancet. 2009; (9677): 1759-60; author reply 1761-2
- Repeatability of published microarray gene expression analyses. Nat Genet. 2009; (2): 149-55
- Replication in genome-wide association studies. Stat Sci. 2009; (4): 561-573
- Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ. 2009: a3006
- Researching genetic versus nongenetic determinants of disease: a comparison and proposed unification. Sci Transl Med. 2009; (7): 7ps8
- STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol. 2009; (7): 581-98
- STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med. 2009; (2): e22
- STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest. 2009; (4): 247-66
- STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med. 2009; (3): 206-15
- Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet. 2009; (2): 131-51
- Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol. 2009; (1): 37-55
- Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol. 2009; (6): 597-608.e4
- Synthesis of observational studies should consider credibility ceilings. J Clin Epidemiol. 2009; (2): 115-22
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; (7): e1000100
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; (4): W65-94
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; (10): e1-34
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009: b2700
- The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009; (8): 559-67
- The elderly were under-represented in osteoarthritis clinical trials. J Clin Epidemiol. 2009; (11): 1218-23
- The use of older studies in meta-analyses of medical interventions: a survey. Open Med. 2009; (2): e62-8
- Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; (11): 1199-206
- Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol. 2009; (5): 537-45
- Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. Am J Hum Genet. 2009; (6): 786-800
- Validating, augmenting and refining genome-wide association signals. Nat Rev Genet. 2009; (5): 318-29
- Mortality in systemic sclerosis. Clin Exp Rheumatol. 2008 Sep-Oct; (5 Suppl 51): S85-93
- 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008; (10): 712-20
- Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008; (1): 120-32
- Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level. Behav Brain Funct. 2008: 46
- Calibration of credibility of agnostic genome-wide associations. Am J Med Genet B Neuropsychiatr Genet. 2008; (6): 964-72
- Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone. Am Heart J. 2008; (1): 23-30
- Doctors' versus patients' global assessments of treatment effectiveness: empirical survey of diverse treatments in clinical trials. BMJ. 2008; (7656): 1287-90
- EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis. 2008; (2): 195-205
- Effect of formal statistical significance on the credibility of observational associations. Am J Epidemiol. 2008; (4): 374-83; discussion 384-90
- Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med. 2008: 14
- Evaluation of networks of randomized trials. Stat Methods Med Res. 2008; (3): 279-301
- Evaluation of the potential excess of statistically significant findings in published genetic association studies: application to Alzheimer's disease. Am J Epidemiol. 2008; (8): 855-65
- Expectations and challenges stemming from genome-wide association studies. Mutagenesis. 2008; (6): 439-44
- Exploring the geometry of treatment networks. Ann Intern Med. 2008; (7): 544-53
- Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers. J Clin Epidemiol. 2008; (5): 464-70
- Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008; (5): 356-69
- Inflated numbers of authors over time have not been just due to increasing research complexity. J Clin Epidemiol. 2008; (6): 546-51
- Interpretation of research results: an indispensable mission impossible? Semin Hematol. 2008; (3): 133-4
- Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008; (5): 951-7
- Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA. 2008; (11): 1277-90
- Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone. 2008; (5): 969-81
- Measuring co-authorship and networking-adjusted scientific impact. PLoS One. 2008; (7): e2778
- Medicine. Life cycle of translational research for medical interventions. Science. 2008; (5894): 1298-9
- Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays. Comput Biol Chem. 2008; (1): 38-46
- Meta-analysis methods. Adv Genet. 2008: 311-34
- Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum Genet. 2008; (1): 1-14
- Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst. 2008; (24): 1780-91
- Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors. Epidemiology. 2008; (1): 75-82
- Perfect study, poor evidence: interpretation of biases preceding study design. Semin Hematol. 2008; (3): 160-6
- Reasons or excuses for avoiding meta-analysis in forest plots. BMJ. 2008; (7658): 1413-5
- Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol. 2008: 31
- Required sample size and nonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci U S A. 2008; (2): 617-22
- Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008; (5): 1148-57
- Some main problems eroding the credibility and relevance of randomized trials. Bull NYU Hosp Jt Dis. 2008; (2): 135-9
- Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008; (7): 827-34
- Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008; (8): e3081
- Why current publication practices may distort science. PLoS Med. 2008; (10): e201
- Why most discovered true associations are inflated. Epidemiology. 2008; (5): 640-8
- Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer. 2007; (17): 2559-79
- An exploratory test for an excess of significant findings. Clin Trials. 2007; (3): 245-53
- Bayesian meta-analysis and meta-regression for gene-disease associations and deviations from Hardy-Weinberg equilibrium. Stat Med. 2007; (3): 553-67
- Claims of sex differences: an empirical assessment in genetic associations. JAMA. 2007; (8): 880-93
- Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab. 2007; (8): 3162-70
- Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis. Cancer Treat Rev. 2007; (1): 24-38
- Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups. Heart. 2007; (4): 450-5
- Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials. Int J Epidemiol. 2007; (2): 422-30
- Genetic and molecular epidemiology. J Epidemiol Community Health. 2007; (9): 757-8
- Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol. 2007; (9): 973-84
- Genetic predisposition to asthma and atopy. Respiration. 2007; (1): 8-12
- Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One. 2007; (9): e841
- Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry. 2007; (7): 784-92
- International ranking systems for universities and institutions: a critical appraisal. BMC Med. 2007: 30
- Is molecular profiling ready for use in clinical decision making? Oncologist. 2007; (3): 301-11
- Limitations are not properly acknowledged in the scientific literature. J Clin Epidemiol. 2007; (4): 324-9
- Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS One. 2007; (2): e196
- Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol. 2007; (4): 450-6
- Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res. 2007; (2): 173-83
- Molecular evidence-based medicine: evolution and integration of information in the genomic era. Eur J Clin Invest. 2007; (5): 340-9
- Non-replication and inconsistency in the genome-wide association setting. Hum Hered. 2007; (4): 203-13
- On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol. 2007; (2): 439-45
- Open letter to the leader of academic medicine. BMJ. 2007; (7586): 191-3
- Osteomyelitis: antigranulocyte scintigraphy with 99mTC radiolabeled monoclonal antibodies for diagnosis-- meta-analysis. Radiology. 2007; (3): 732-41
- PCI for stable coronary disease. N Engl J Med. 2007; (4): 414-5; author reply 417-8
- Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients. Am Heart J. 2007; (6): 1065-71
- Persistence of contradicted claims in the literature. JAMA. 2007; (21): 2517-26
- Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field. Pharmacogenomics. 2007; (8): 933-58
- Prosthesis infection: diagnosis after total joint arthroplasty with antigranulocyte scintigraphy with 99mTc-labeled monoclonal antibodies--a meta-analysis. Radiology. 2007; (1): 101-8
- Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007; (3): 236-43
- Reporting of systematic reviews: the challenge of genetic association studies. PLoS Med. 2007; (6): e211
- Selection in reported epidemiological risks: an empirical assessment. PLoS Med. 2007; (3): e79
- Selective discussion and transparency in microarray research findings for cancer outcomes. Eur J Cancer. 2007; (13): 1999-2010
- Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007; (10): 898-911
- The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007; (8): 1091-6
- The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology. 2007; (1): 1-8
- Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol. 2007; (8): 863-6
- Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007; (7626): 914-6
- Why most published research findings are false: author's reply to Goodman and Greenland. PLoS Med. 2007; (6): e215
- A heterogeneity-based genome search meta-analysis for autism-spectrum disorders. Mol Psychiatry. 2006; (1): 29-36
- A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006; (1): 3-5
- Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006; (1): 312-24
- Adverse events: the more you search, the more you find. Ann Intern Med. 2006; (4): 298-300
- An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment. Pharmacogenet Genomics. 2006; (10): 705-11
- Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006; (6): 661-70
- Commentary: grading the credibility of molecular evidence for complex diseases. Int J Epidemiol. 2006; (3): 572-8; discussion 593-6
- Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. J Natl Cancer Inst. 2006; (19): 1350-3
- Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006; (5): 635-41
- Concentration of the most-cited papers in the scientific literature: analysis of journal ecosystems. PLoS One. 2006: e5
- Concordance of functional in vitro data and epidemiological associations in complex disease genetics. Genet Med. 2006; (9): 583-93
- Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ. 2006; (7561): 224
- Evolution and translation of research findings: from bench to where? PLoS Clin Trials. 2006; (7): e36
- Extreme between-study homogeneity in meta-analyses could offer useful insights. J Clin Epidemiol. 2006; (10): 1023-32
- Family-based versus unrelated case-control designs for genetic associations. PLoS Genet. 2006; (8): e123
- Gene expression profiling for individualized breast cancer chemotherapy: success or not? Nat Clin Pract Oncol. 2006; (10): 538-9
- Heterogeneity-based genome search meta-analysis for preeclampsia. Hum Genet. 2006; (3): 360-70
- Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol. 2006; (4): 300-9
- Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol. 2006; (7): 609-14
- Indirect comparisons: the mesh and mess of clinical trials. Lancet. 2006; (9546): 1470-2
- Journals should publish all "null" results and should sparingly publish "positive" results. Cancer Epidemiol Biomarkers Prev. 2006; (1): 186
- Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 2006; (11): 917-23
- Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med. 2006; (4): e90
- Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006; (7549): 1061-4
- Patient outcomes with teaching versus nonteaching healthcare: a systematic review. PLoS Med. 2006; (9): e341
- Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data. Eur J Cancer. 2006; (3): 319-26
- Self-reported health in high and very high incomes. Qual Life Res. 2006; (3): 547-58
- Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst. 2006; (22): 1655-63
- Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst. 2006; (18): 1285-91
- Susceptibility to HIV infection--disentangling host genetics and host behavior. J Infect Dis. 2006; (1): 4-6
- The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann Intern Med. 2006; (4): 255-64
- The case of the misleading funnel plot. BMJ. 2006; (7568): 597-600
- The importance of independent risk-factors for long-term mortality prediction after cardiac surgery. Eur J Clin Invest. 2006; (9): 599-607
- Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone. 2006; (4): 938-45
- Microarrays and molecular research: noise discovery? Lancet. 2005 Feb 5-11; (9458): 454-5
- 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med. 2005; (6): 958-63
- A network of investigator networks in human genome epidemiology. Am J Epidemiol. 2005; (4): 302-4
- Ala45Thr polymorphism of the NEUROD1 gene and diabetes susceptibility: a meta-analysis. Hum Genet. 2005; (3): 192-9
- Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2005; (3): CD005064
- Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005; (1): 176-81
- Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2005; (3): CD005063
- CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE Review and meta-analysis. Am J Epidemiol. 2005; (1): 3-16
- CYP2D6 polymorphisms and the risk of tardive dyskinesia in schizophrenia: a meta-analysis. Pharmacogenet Genomics. 2005; (3): 151-8
- Comparison of large versus smaller randomized trials for mental health-related interventions. Am J Psychiatry. 2005; (3): 578-84
- Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005; (2): 218-28
- Creatine kinase-MB elevation following stent implantation. J Am Coll Cardiol. 2005; (11): 1908; author reply 1908-9
- Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol. 2005; (6): 543-9
- Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis. Obstet Gynecol. 2005; (5 Pt 1): 1104-13
- HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005; (18): 3672-3
- Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005; (7): 840-8
- Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005; (2): 123-37
- International collaboration, funding and association with burden of disease in randomized controlled trials in Africa. Bull World Health Organ. 2005; (7): 511-7
- Large scale evidence and replication: insights from rheumatology and beyond. Ann Rheum Dis. 2005; (3): 345-6
- Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med. 2005; (12): e334
- Meta-analysis comparing drug-eluting stents with bare metal stents. Am J Cardiol. 2005; (5): 640-3
- Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol. 2005; (5): 963-72
- Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005; (5): 359-69
- Molecular bias. Eur J Epidemiol. 2005; (9): 739-45
- Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med. 2005; (1): 2-10
- Multivariate models of self-reported health often neglected essential candidate determinants and methodological issues. J Clin Epidemiol. 2005; (5): 436-43
- Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005; (3): 188-94
- Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol. 2005; (1): 89-95
- Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005; (22): 2906-12
- Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. J Thorac Cardiovasc Surg. 2005; (2): 314-21
- Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res. 2005; (4): 1434-40
- Relative citation impact of various study designs in the health sciences. JAMA. 2005; (19): 2362-6
- Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'. AIDS. 2005; (12): 1336-7
- Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005; (14): 1043-55
- Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol. 2005; (3): 336-42
- Unavailability of online supplementary scientific information from articles published in major journals. FASEB J. 2005; (14): 1943-4
- Why most published research findings are false. PLoS Med. 2005; (8): e124
- Cyclophosphamide in systemic sclerosis: light and shadows. Clin Exp Rheumatol. 2004 Sep-Oct; (5): 551-2
- Diagnosis of sensorineural hearing loss with neural networks versus logistic regression modeling of distortion product otoacoustic emissions. Audiol Neurootol. 2004 Mar-Apr; (2): 81-7
- 'Racial' differences in genetic effects for complex diseases. Nat Genet. 2004; (12): 1312-8
- Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2004; (9): 1655-62
- Availability of large-scale evidence on specific harms from systematic reviews of randomized trials. Am J Med. 2004; (8): 582-9
- Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004; (10): 781-8
- Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials. JAMA. 2004; (2): 237-42
- Diagnostic performance of coronary magnetic resonance angiography as compared against conventional X-ray angiography: a meta-analysis. J Am Coll Cardiol. 2004; (9): 1867-76
- Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004; (12): 2393-404
- Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA. 2004; (17): 2105-14
- Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. J Clin Epidemiol. 2004; (11): 1124-30
- Establishment of genetic associations for complex diseases is independent of early study findings. Eur J Hum Genet. 2004; (9): 762-9
- Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr. 2004; (32): 23-31
- Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics. 2004; (1): e111-8
- Global estimates of high-level brain drain and deficit. FASEB J. 2004; (9): 936-9
- Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis. AIDS. 2004; (16): 2153-61
- Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med. 2004; (1): 5
- Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS. 2004; (1): 99-108
- Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am J Epidemiol. 2004; (6): 527-36
- Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis. Clin Cancer Res. 2004; (18 Pt 1): 6208-14
- Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2004; (3): 888-95
- Randomized trials of neurosurgical interventions: a systematic appraisal. Neurosurgery. 2004; (1): 18-25; discussion 25-6
- Safety reporting in randomized trials of mental health interventions. Am J Psychiatry. 2004; (9): 1692-7
- The Decameron of poor research. BMJ. 2004; (7480): 1436-40
- The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies. J Clin Epidemiol. 2004; (4): 341-8
- The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Biomed Pharmacother. 2004; (5): 286-91
- The value of meta-analysis in rheumatology research. Autoimmun Rev. 2004: S57-9
- Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int. 2004; (2): 753-60
- Treatment options for acute sinusitis in children. Curr Allergy Asthma Rep. 2004; (6): 471-7
- UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol. 2004; (4): 512-21
- 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med. 2003; (5): 717-24
- Acute sinusitis in children: current treatment strategies. Paediatr Drugs. 2003; (2): 71-80
- Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens. 2003; (7): 1221-8
- Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2003; (2): 120-6
- Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford). 2003; (5): 645-51
- Awareness of the side effects of possessed medications in a community setting. Eur J Clin Pharmacol. 2003; (12): 821-7
- Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis. 2003; (1): 29-37
- Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus. J Rheumatol. 2003; (5): 979-84
- Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol. 2003; (5 Pt 1): 1009-16
- Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis. J Acquir Immune Defic Syndr. 2003; (1): 70-6
- Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003; (3): 377-87
- Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS. 2003; (11): 1631-8
- Evaluation of cluster randomized controlled trials in sub-Saharan Africa. Am J Epidemiol. 2003; (9): 921-6
- Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. Rheumatology (Oxford). 2003; (2): 357-61
- Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003; (9357): 567-71
- Genetic associations: false or true? Trends Mol Med. 2003; (4): 135-8
- HIV lipodystrophy case definition using artificial neural network modelling. Antivir Ther. 2003; (5): 435-41
- HIV: opportunistic infections. Clin Evid. 2003; (9): 795-816
- HIV: prevention of opportunistic infections. Clin Evid. 2003; (10): 809-30
- Important drug safety information on the internet: assessing its accuracy and reliability. Drug Saf. 2003; (7): 519-27
- Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol. 2003; (1): 26-32
- Is vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2003; (2): 330-5
- Isolated intraparotid Kaposi sarcoma in human immunodeficiency virus type 1 infection. Mayo Clin Proc. 2003; (12): 1561-3
- Late-starter sites in randomized controlled trials. J Clin Epidemiol. 2003; (5): 408-15
- Levels of absolute survival benefit for systemic therapies of advanced cancer. a call for standards. Eur J Cancer. 2003; (9): 1194-8
- Modelling of escalating outpatient antibiotic expenditures. J Antimicrob Chemother. 2003; (6): 1001-4
- Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol. 2003; (8): 1406-11
- Mother-to-child transmission of HIV: developing integration of healthcare programmes with clinical, social and basic research studies. Report of the International Workshop held at Chobe Marina Lodge, Kasane, Botswana, 21-25 January 2003. Acta Paediatr. 2003; (11): 1343-8
- Nail pigmentation and fatigue in a 39-year-old woman. Clin Infect Dis. 2003; (3): 348, 378-9
- Number of published systematic reviews and global burden of disease: database analysis. BMJ. 2003; (7423): 1083-4
- Physical examination. Lancet. 2003; (9400): 2023; author reply 2024
- Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet. 2003; (9394): 1439-44
- Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time. Eur J Cancer. 2003; (16): 2278-87
- Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis. Arthritis Rheum. 2003; (7): 1930-8
- SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2003; (7): 618-24
- Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol. 2003; (5): 1330-5
- Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda. Clin Infect Dis. 2003; (Suppl 1): S13-24
- The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int. 2003; (4): 1475-82
- The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. Cancer. 2003; (3): 581-9
- Translation of highly promising basic science research into clinical applications. Am J Med. 2003; (6): 477-84
- Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2003; (12): 1395-402
- Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses. 2002; (11): 741-6
- Association of polymorphisms of the estrogen receptor alpha gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res. 2002; (11): 2048-60
- Association of polymorphisms of the oestrogen receptor alpha gene with the age of menarche. Hum Reprod. 2002; (4): 1101-5
- Citation of randomized evidence in support of guidelines of therapeutic and preventive interventions. J Clin Epidemiol. 2002; (6): 545-55
- Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol. 2002; (3): 204-10
- Conduction delay within the coronary sinus in humans: implications for atrial arrhythmias. J Cardiovasc Electrophysiol. 2002; (9): 859-62
- Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA. 2002; (22): 2973-82
- Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. J Rheumatol. 2002; (2): 298-304
- Design and quality considerations for randomized controlled trials in systemic sclerosis. Arthritis Rheum. 2002; (1): 73-81
- Electrocardiogram-gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol. 2002; (12): 2059-68
- Improving safety reporting from randomised trials. Drug Saf. 2002; (2): 77-84
- Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum. 2002; (3): 741-7
- Management of clinically inapparent adrenal mass. Evid Rep Technol Assess (Summ). 2002; (56): 1-5
- Opportunistic infections and HIV. Clin Evid. 2002; (7): 717-37
- Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2002; (10): 2129-35
- Protein conjugate pneumococcal vaccines. BMJ. 2002; (7340): 750-1
- Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ. 2002; (7339): 702
- Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2002; (7): 780-6
- Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum. 2002; (6): 1563-71
- Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations. Semin Arthritis Rheum. 2002; (6): 361-70
- Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. J Clin Epidemiol. 2002; (6): 619-26
- Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001 Jan 24-31; (4): 437-43
- Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis. Ann Emerg Med. 2001; (5): 461-70
- Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med. 2001; (5): 478-94
- Accuracy of imaging technologies in the diagnosis of acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med. 2001; (5): 471-7
- Any casualties in the clash of randomised and observational evidence? BMJ. 2001; (7291): 879-80
- Appendicectomies in Albanians in Greece: outcomes in a highly mobile immigrant patient population. BMC Health Serv Res. 2001: 5
- Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res. 2001; (9): 1586-92
- Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics. J Rheumatol. 2001; (8): 1881-7
- C-Reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem. 2001; (5): 882-6
- Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001; (7): 821-30
- Comparison of myocardial fractional flow reserve and intravascular ultrasound for the assessment of slotted-tube stents. Catheter Cardiovasc Interv. 2001; (3): 322-6; discussion 327
- Declaring competing interests. Types of competing interests would be of interest. BMJ. 2001; (7322): 1187-8
- Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies. BMC Med Res Methodol. 2001: 4
- Diagnosing acute cardiac ischemia in the emergency department: a systematic review of the accuracy and clinical effect of current technologies. Ann Emerg Med. 2001; (5): 453-60
- Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis. Clin Infect Dis. 2001; (11): 1901-9
- Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling. J Am Coll Cardiol. 2001; (2): 521-8
- Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol. 2001; (9): 873-80
- Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med. 2001; (9): 782-95
- Evidence on interventions to reduce medical errors: an overview and recommendations for future research. J Gen Intern Med. 2001; (5): 325-34
- Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proc Natl Acad Sci U S A. 2001; (3): 831-6
- How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study. J Rheumatol. 2001; (4): 798-801
- Identification and catheter ablation of extracardiac and intracardiac components of ligament of Marshall tissue for treatment of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2001; (7): 750-8
- Management of cancer pain. Evid Rep Technol Assess (Summ). 2001; (35): 1-5
- Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother. 2001; (5): 691-703
- Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for upper respiratory tract infections. J Antimicrob Chemother. 2001; (5): 677-89
- Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease. Blood. 2001; (5): 1634-5
- Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. Clin Infect Dis. 2001; (1): 76-82
- Patterns of patient enrollment in randomized controlled trials. J Clin Epidemiol. 2001; (9): 877-83
- Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis. 2001; (4): 539-45
- Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data. J Clin Epidemiol. 2001; (3): 245-52
- Replication validity of genetic association studies. Nat Genet. 2001; (3): 306-9
- Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol. 2001: 3
- Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome. Ann Rheum Dis. 2001; (1): 43-8
- Technical report: evidence for the diagnosis and treatment of acute uncomplicated sinusitis in children: a systematic overview. Pediatrics. 2001; (3): E57
- The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int. 2001; (4): 326-31
- Arabian nights-1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report. BMJ. 2000 Dec 23-30; (7276): 1563-4
- 23-valent pneumococcal vaccination and HIV. Lancet. 2000; (9234): 1027-8
- A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS. AIDS. 2000; (9): F83-93
- Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis. 2000; (3): 217-22
- Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med. 2000; (3): 198-204
- B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Am J Respir Cell Mol Biol. 2000; (3): 344-51
- Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum. 2000; (5): 296-304
- Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. Eur J Clin Invest. 2000; (7): 646-52
- Clinically significant and biopsy-documented renal involvement in primary Sjögren syndrome. Medicine (Baltimore). 2000; (4): 241-9
- Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol. 2000; (19): 3409-22
- Diagnosis and treatment of uncomplicated acute sinusitis in children. Evid Rep Technol Assess (Summ). 2000; (9 Suppl): 1-3
- Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. AIDS. 2000; (11): 1481-8
- Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy. AIDS. 2000; (7): 821-6
- Evaluation of technologies for identifying acute cardiac ischemia in emergency departments. Evid Rep Technol Assess (Summ). 2000; (26): 1-4
- Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. J Infect Dis. 2000; (3): 965-9
- Meta-analysis in hematology and oncology. Hematol Oncol Clin North Am. 2000; (4): 973-91
- NF-kappa B modulates TNF-alpha production by alveolar macrophages in asymptomatic HIV-seropositive individuals. J Immunol. 2000; (3): 1588-94
- Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 2000; (8): 628-34
- Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. QJM. 2000; (8): 523-30
- Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int. 2000; (1): 258-64
- Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM. 2000; (3): 169-74
- Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia. J Infect Dis. 1999; (6): 2044-7
- Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1999; (2): 129-36
- HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. Hum Immunol. 1999; (12): 1274-80
- Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis. Lancet. 1999; (9178): 569-70
- Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med. 1999; (22): 1698-700
- Pooling research results: benefits and limitations of meta-analysis. Jt Comm J Qual Improv. 1999; (9): 462-9
- Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Int J Epidemiol. 1999; (4): 769-75
- Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology (Oxford). 1999; (12): 1228-33
- Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data. J Clin Epidemiol. 1999; (4): 281-91
- Relationship between event rates and treatment effects in clinical site differences within multicenter trials: an example from primary Pneumocystis carinii prophylaxis. Control Clin Trials. 1999; (3): 253-66
- Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum. 1999; (1): 1-3
- State of the evidence: current status and prospects of meta-analysis in infectious diseases. Clin Infect Dis. 1999; (5): 1178-85
- Analysis of life-long strategies to prevent Pneumocystis carinii pneumonia in patients with variable HIV progression rates. AIDS. 1998; (11): 1317-25
- Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 1998; (7159): 632-7
- Can quality of clinical trials and meta-analyses be quantified? Lancet. 1998; (9128): 590-1
- Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis. 1998; (2): 349-59
- Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA. 1998; (4): 281-6
- Evaluation of guidelines for initiation of highly active antiretroviral therapy in a longitudinal cohort of HIV-infected individuals. AIDS. 1998; (18): 2417-23
- Genetic effects on HIV disease progression. Nat Med. 1998; (5): 536
- Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. Am J Epidemiol. 1998; (11): 1117-26
- Issues in comparisons between meta-analyses and large trials. JAMA. 1998; (14): 1089-93
- Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med. 1998; (18): 1261-8
- Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; (2): 126-35
- Meta-analyses and large randomized, controlled trials. N Engl J Med. 1998; (1): 59; author reply 61-2
- Reporting of safety data from randomised trials. Lancet. 1998; (9142): 1752-3
- Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop. Stat Med. 1998; (21): 2435-62
- Summing up evidence: one answer is not always enough. Lancet. 1998; (9096): 123-7
- Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient. J Clin Epidemiol. 1998; (8): 709-11
- Use of neural networks to model complex immunogenetic associations of disease: human leukocyte antigen impact on the progression of human immunodeficiency virus infection. Am J Epidemiol. 1998; (5): 464-71
- Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: a meta-analysis of diagnostic test characteristics. Hepatology. 1997; (4): 1035-44
- Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; (1): 22-30
- Quantitative synthesis in systematic reviews. Ann Intern Med. 1997; (9): 820-6
- The impact of high-risk patients on the results of clinical trials. J Clin Epidemiol. 1997; (10): 1089-98
- The relationship between study design, results, and reporting of randomized clinical trials of HIV infection. Control Clin Trials. 1997; (5): 431-44
- Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA. 1996 Oct 23-30; (16): 1332-8
- A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med. 1996; (2): 177-88
- Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection. Am J Epidemiol. 1996; (11): 1074-85
- On meta-analyses of meta-analyses. Lancet. 1996; (9029): 756
- Predictive value of viral load measurements in asymptomatic untreated HIV-1 infection: a mathematical model. AIDS. 1996; (3): 255-62
- Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 1996; (7027): 338-45
- Pneumococcal aortitis in the antibiotic era. Arch Intern Med. 1995 Aug 7-21; (15): 1678-80
- Aspergillus fumigatus infection of a biloma. Clin Infect Dis. 1995; (5): 1427-8
- Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness. Ann Intern Med. 1995; (11): 856-66
- Human leukocyte antigen associations of epidemic Kaposi's sarcoma. AIDS. 1995; (6): 649-51
- Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am J Pathol. 1995; (5): 1200-6
- Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis. 1995; (2): 390-7
- Insulin-dependent diabetes in AIDS. AIDS. 1994; (4): 556-7
- Risk of gastrointestinal bleeding from dexamethasone in children with bacterial meningitis. Lancet. 1994; (8900): 792
Help
Trial Administration